Neurona Therapeutics Appoints James Stutz as Chief Financial Officer
Neurona Therapeutics announced the appointment of James Stutz as Chief Financial Officer. James brings over 20 years of experience in the biopharma industry, and most recently, served as Chief Business Officer at Actym Therapeutics. His career also includes roles as CFO at Tolerion and CBO at Tioma Therapeutics.
Neurona Therapeutics is a provider of cell-based medicines dealing with neurological disorders.